EPISODE · Nov 25, 2024 · 27 MIN
Bill Enright, CEO, Barinthus Biotherapeutics
from CEOs You Should Know: Washington DC · host iHeartMedia Washington DC
William "Bill" Enright is a seasoned biotech executive with more than thirty years of experience in building and financing both privately held and publicly held companies. Bill spent more than ten years at Altimmune (NASDAQ: ALT) as a Director, President & CEO, moving multiple programs into clinical testing, completing several acquisitions and eventually taking the company public.See omnystudio.com/listener for privacy information.
Embed this episode
What this episode covers
William "Bill" Enright is a seasoned biotech executive with more than thirty years of experience in building and financing both privately held and publicly held companies. Bill spent more than ten years at Altimmune (NASDAQ: ALT) as a Director,...
NOW PLAYING
Bill Enright, CEO, Barinthus Biotherapeutics
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.